Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions

Current Opinion in Hematology

Volumn 5, Issue 6, 1998, Pages 391-395

  Price, Thomas H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BLOOD TRANSFUSION; CELL COUNT; CHILL; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEVER; GRANULOCYTE TRANSFUSION; HUMAN; HUMAN CELL; LEUKAPHERESIS; MAJOR CLINICAL STUDY; META ANALYSIS; NEUTROPHILIA; PRIORITY JOURNAL;

EID: 0031774874     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199811000-00007     Document Type: Article

References (35)

1. Strauss RG: Therapeutic granulocyte transfusions in 1993. Blood 1993, 81:1675-1678.
2. Vamvakas EC, Pineda AA: Determinants of the efficacy of prophylactic granulocyte transfusions: A meta-analysis. J Clin Apheresis 1997, 12:74-81.
3. Dale DC, Liles WC, Price TH: Renewed interest in granulocyte transfusion therapy. Br J Haematol 1997, 98:497-501.
4. Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB: Granulocyte transfusion therapy of experimental pseudomonas septicemia: Study of cell dose and collection technique. Blood 1978, 52:323-331.
5. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA: Neutrophil kinetics in man. J Clin Invest 1976, 58:705-715.
6. Lee J-H, Leitman SF, Klein HG: A controlled comparison of the efficacy of pentastarch and pentastarch in granulocyte collections by centrifugal leukapheresis. Blood 1995, 86:4662-4666.
7. Chatta GS, Price TH, Allen RC, Dale DC: Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 1994, 84:2923-2929.
8. Price TH, Chatta GS, Dale DC: Effect of recombinant granulocyle colony stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996, 88:335-340.
9. Dale DC, Liles WC, Summer WR, Nelson S: Review: Granulocyte colony-stimulating factor-role and relationships in infectious diseases. J Infect Dis 1995, 172:1061-1075.
10. Cohen DM, Bhalla SC, Anaissie EJ, Hester JP, Savary CA, Rex JH: Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils: Implications for white blood cell transfusion therapy Clin Lab Haematol 1997, 19:39-47.
11. Liles WC, Huang JE, van Burik JH, Bowden RA, Dale DC: Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis 1997, 175:1012-1015. A study demonstrating that granulocyte colony-stimulating factor (G-CSF) administered in vivo enhances the antifungal activity of circulating neutrophils, particularly against Aspergillus and Rhizopus. These results suggest that granulocytes collected from G-CSF stimulated donors may be of increased value in the treatment of patients with fungal infection.
12. Murea S, Fruehauf S, Zeller WJ, Haas R: Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hours. J Hematother 1996, 5:351-357.
13. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, et al.: The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993, 81:1883-1888.
14. Casper CB, Seger RA, Burger J, Gmür J: Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993, 81:2866-2871.
15. Hester JP, Dignani MC, Anaissie EJ, Kantarjian HM, O'Brien S, Freireich EJ: Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis 1995, 10:188-193.
16. Adkins D, Spitzer G, Johnston M, Velasquez W, Dunphy F, Petruska P: Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: Analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion 1997, 37:737-748.
17. Liles WC, Huang JE, Llewellyn C, SenGupta D, Price TH, Dale DC: A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion 1997, 37:182-187. Comparison of various granulocyte colony-stimulating factor and corticosteroid donor stimulating schedules.
18. Price TH, Bowden RA, Boeckh M, Liles WC, Llewellyn C, Fuller F, Dale DC: Neutrophil collection from community apheresis donors after granulocyte colony-stimulating factor and dexamethasone stimulation: Feasibility and efficacy [abstract]. Blood 1997, 90(suppl 1):137b.
19. Price TH: Blood center perspective of granulocyte transfusions: Future applications. J Clin Apheresis 1995, 10:119-123.
20. Bowden R, Price T, Boeckh M, Liles C, Cays M, Dale D: Phase I/II study of granulocyte transfusions from G-CSF-stimulated unrelated donors for treatment infections in neutropenic blood and marrow transplant (BMT) patients [abstract]. Blood 1997, 90(suppl 1):435a.
21. Leitman SF, Oblitas JM, Emmons R, Dunn DE, Young NS: Clinical efficacy of daily G-CSF-recruited granulocyte transfusions in patients with severe neutropenia and life-threatening infections [abstract]. Blood 1996, 88(suppl 1):331a.
22. Grigg A, Vecchi L, Bardy P, Szer J: G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis. Aust N Z J Med 1996, 26:813-818.
23. Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH: Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor (G-CSF) and dexamethasone. Transfusion 1998, AU: please update Determination of kinetics and function of neutrophils collected from normal donors after stimulation with granulocyte colony-stimulating factor and dexarrethasone. The cells exhibit normal bactericidal activity, enhanced surface expression of proteins associated with host defenses and cell adhesion, prolonged intravascular survival, and normal extravascular migration.
24. Adkins D, Goodgold H, Hendershott L, Johnston M, Cravens D, Spitzer G: Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1997, 19:809-812. Use of 111 -indium labeling to demonstrate that neutrophils collected from granulocyte colony-stimulating factor stimulated donors are capable of localizing to sites of inflammation in recipients of the cells.
25. von Planta M, Ozsahin H, Schroten H, Stauffer UG, Seger RA: Greater omentum flaps and granulocyte transfusions as combined therapy of liver abscess in chronic granulomatous disease. Eur J Pediatr Surg 1997, 7:234-236.
26. Di Mario A, Sica S, Salutari P, La Barbera EO, Marra R, Leone G: Granulocyte colony-stimulating factor-primed leukocyte tranfusions in Candida tropicalis fungemia in neutropenic patients. Haematologica 1997, 82:362-363.
27. Catalano L, Fontana R, Scarpato N, Picardi M, Rocco S, Rotoli B: Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation. Haematologica 1997, 82:71-72.
28. Clarke K, Szer J, Shelton M, Coghlan D, Grigg A: Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection. Bone Marrow Transplant 1995, 16:723-726.
29. Taylor K, Moore D, Kelly C, Wright S, Rodwell R, Bashford J, et al.: Safety and logistical use of filgrastim (FG) mobilised granulocytes (FMG) in early management of severe neutropenic sepsis (SNS) in acute leukemia (AL)/autograft [abstract]. Blood 1996, 88(suppl 1):349a.
30. Harada M, Nagafuji K, Fujisaki T, Kubota A, Mizuno S-I, Takenaka K, et al.: G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation. J Hematother 1996, 5:63-71.
31. Stroncek DF, day ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, McCullough J: Treatment of normal individuals with granulocyte-colony-stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996, 36:601-610,
32. Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, et al.: Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 1996, 36:590-595.
33. Becker PS, Wagle M, Matous S, Swanson RS, Pihan G, Lowry PA, et al.: Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): Occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 1997, 3:45-49.
34. Stroneck DF, Clay ME, Herr G, Smith J, Ilstrup S, McCullough J: Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion 1997, 37:304-308. One year follow-up study of donors stimulated with granulocyte colony-stimulating factor, demonstrating that there were no long-term effects.
35. Sakamaki S, Matsunga T, Hirayama Y, Kuga T, Niitsu Y: Haematological study of healthy volunteers 5 years after G-CSF. Lancet 1995, 346:1432-1433.